Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study Meeting Abstract
| Authors: | Loriot, Y.; Rosenberg, J. E.; Powles, T. B.; Necchi, A.; Hussain, S.; Morales, R.; Retz, M.; Niegisch, G.; Duran, I.; Theodore, C.; Perez-Gracia, J. L.; Pulido, E. G.; Thastrom, A.; Danner, B.; Mariathasan, S.; Abidoye, O.; van der Heijden, M. |
| Abstract Title: | Atezolizumab (atezo) in platinum (plat)-treated locally advanced/metastatic urothelial carcinoma (mUC): Updated OS, safety and biomarkers from the Ph II IMvigor210 study |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi270 |
| Language: | English |
| ACCESSION: | WOS:000393912500779 |
| DOI: | 10.1093/annonc/mdw373.11 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 783P -- Source: Wos |
